CD7 and acute lymphoblastic leukemia: CD7 is a pan-T antigen widely expressed during T differentiation stages from progenitors to mature T/NK cells, and steadily expressed on the majority of T-ALL, making its targeting at risk of profound T-cell aplasia and intensive supportive care [31,32].